Tambiling, Gleceria G.

HRN: 28-51-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
CEFTRIAXONE 1G (VIAL)
02/02/2026
02/09/2026
IV
2g
OD
Soft Tissue Injury Sec To MVA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: